Cambridge Cognition and Aardex collaborate to boost decentralised clinical trials
Partnership involves the study of real-time patient data and identification of adherence issues
Read More
Tag: cambridge cognition
- Nuclera and leadXpro partner to accelerate structure‑based drug design
- Lundbeck reports positive phase 2b results for migraine prevention drug
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
